Harold Barron, who took over GlaxoSmithKline's chief scientific officer in 2017, is leaving to head up the Silicon Valley biotech Altos Labs. Before joining GSK, he was president of Research and Development at Calico, a Google-backed, anti-ageing biotech that hopes to extend the human lifespan by treating age-related diseases.
Submitted by Tiffany Penn on February 01, 2022